๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Expression of androgen receptor and growth factors in premalignant lesions of the prostate

โœ Scribed by Harper, Maureen E.; Glynne-Jones, Eve; Goddard, Lindy; Mathews, Phillip; Nicholson, Robert I.


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
597 KB
Volume
186
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

โœฆ Synopsis


Analysis of growth factors and receptors in putative premalignant lesions of prostatic adenocarcinoma should aid our understanding of their growth pathways. Sixty prostatic TURP (transurethral resection of the prostate) specimens exhibiting atypical adenomatous hyperplasia (AAH) and/or prostatic intraepithelial neoplasia (PIN) lesions were assayed by immunohistochemistry for androgen receptor (AR), epidermal growth factor receptor (EGFR), c-erbB-2, transforming growth factor-alpha (TGF-), vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), MIB-1, E-cadherin, and high molecular weight keratin. Expression of these factors in the lesions was compared with that in the co-existing benign prostatic hyperplasia (BPH) or prostatic adenocarcinoma. Strong AR nuclear staining was observed in the luminal cells, but not the basal cells, of BPH and PIN lesions and in all the carcinomas examined. A similar growth factor and receptor profile was demonstrated in the secretory epithelium of high-grade PIN and carcinoma with a tendency to higher expression of membranous EGFR and c-erbB-2 and cytoplasmic TGF-, and lower levels of FGF-2 than in low-grade PIN or BPH glands. Also, increased rates of proliferation, as estimated by MIB-1 stained cells, were observed in high-grade PIN in comparison with low-grade PIN and BPH and were not confined to the basal layer. AAH lesions resembled neither BPH nor carcinoma. Proliferation was virtually absent (MIB-1 expression); both AR and E-cadherin expression was significantly reduced; and, with the exception of FGF-2, all the other growth factors and receptors studied were absent. The results presented would support a premalignant role for high-grade PIN, whilst AAH would appear to represent a quiescent phenotype unlikely to progress to neoplasia.


๐Ÿ“œ SIMILAR VOLUMES


Androgenic regulation of growth factor a
โœ Russell B. Myers; Denise Oelschlager; Upender Manne; Patricia N. Coan; Heidi Wei ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 314 KB ๐Ÿ‘ 2 views

The effects of androgen manipulation on epidermal growth factor (EGF) receptor, p185 erbB-2 and transforming growth factor-โฃ (TGF-โฃ) levels were examined in prostatic adenocarcinoma. Male nude mice were inoculated with the CWR22 androgen-dependent human prostatic tumor or an androgenindependent (CWR

Expression, structure, and function of a
โœ Culig, Zoran; Hobisch, Alfred; Hittmair, Anton; Peterziel, Heike; Cato, Andrew C ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 53 KB ๐Ÿ‘ 2 views

## BACKGROUND. Endocrine therapy for prostate cancer aims to reduce the levels of circulating androgen or to inhibit androgen action by blocking the androgen receptor in the prostate, or both. Studies in various animal and human prostate cancer models suggested that there may be a downregulation o